‘March-in’ rights: Why Biden’s changes contradict the point of the Bayh-Dole Act

The unintended consequences of President Biden’s proposal to dictate prices would destroy the US’ thriving tech transfer framework—and in industries far beyond pharmaceuticals, explain former USPTO directors Andrei Iancu and David Kappos.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

IP under Biden: what does the future look like?

10 November 2020 US President-elect Joe Biden is pushing forward with his plans for office, but what effect will his presidency have on IP?

The Biden administration’s trade policy: what will it mean for IP?

14 December 2020 The incoming US presidential administration has made it clear that it will prioritise trade policy and undo a number of Trump’s decisions in this area, which could lead to significant ramifications for IP. Michael Nesheiwat and Jess Collen of law firm Collen IP report.

Ex-Clifford Chance tech counsel joins White & Case

Bitter blow for Coca-Cola as sweetener patent revoked in Europe

On our radar…

Making sense of US subject matter eligibility for AI businesses

Gibson targets ‘Trump’ guitars after separate $18m fakes bust

Judge grants Citi restraining order against former banker in secrets suit

‘There’s real money here’: Meta, Lenovo reveal gender-based inventor stats

Arusha Protocol takes root: Fresh growth for plant variety protection in Africa

‘March-in’ rights: Why Biden’s changes contradict the point of the Bayh-Dole Act

More on this story

Editor's picks

Editor's picks

More articles